Related Experiment Videos
Human immunodeficiency virus type 1 productive infection in staurosporine-blocked quiescent cells
1URA-CNRS, Laboratoire d'Immunobiologie, Faculté de Médecine, Paris, France.
Abstract:
Staurosporine, an antibiotic known to inhibit cellular protein kinases, can reversibly block the progress of normal and tumour cells into the cell cycle. The ability of HIV-1 to infect and replicate in cells blocked by staurosporine was investigated. The results show that blocked, non-cycling cells can be productively infected by HIV-1, steadily releasing infectious progeny virus for several weeks. This suggests that at least in some cases, HIV-1 can be found in a stable and active state in resting, non-proliferating T cells.
Insights
Human immunodeficiency virus type 1 (HIV-1) can infect and replicate in non-cycling cells. This indicates HIV-1 can remain active in resting T cells.
Area of Science:
- Virology
- Cell Biology
- Immunology
Background:
- Staurosporine is an antibiotic that inhibits protein kinases, reversibly blocking cell cycle progression in normal and tumor cells.
- Understanding HIV-1 replication in non-proliferating cells is crucial for developing effective antiviral strategies and understanding viral persistence.
Purpose of the Study:
- To investigate the ability of human immunodeficiency virus type 1 (HIV-1) to infect and replicate in cells arrested in the cell cycle by staurosporine.
Main Methods:
- Normal and tumor cells were treated with staurosporine to induce cell cycle arrest.
- These blocked cells were then infected with HIV-1.
- Viral replication and progeny virus release were monitored over time.
Main Results:
- Cells blocked in the cell cycle by staurosporine were productively infected by HIV-1.
- Infectious progeny virus was steadily released from these non-cycling cells for several weeks.
- This demonstrates that HIV-1 can actively replicate in resting, non-proliferating T cells.
Conclusions:
- HIV-1 can establish a stable and active infection in resting, non-proliferating T cells.
- These findings suggest that resting T cells can serve as a reservoir for persistent HIV-1 infection.
- Further research is needed to explore the implications for HIV-1 latency and therapeutic interventions.